IonQ, Inc. IONQ shares are trading higher Wednesday, though the stock remains down by more than 30% over the last month.
What To Know:
On Monday, Morgan Stanley analyst Scott Fessler maintained IonQ with an Equal-Weight and lowered the price target from $16 to $12.
On Oct. 24, the company announced that its co-founder and chief scientist, Dr. Chris Monroe, will depart the company to return to his academic, research and policy pursuits.
IONQ shares have attracted attention from retail investors and short-sellers alike. According to data from Benzinga Pro, 16.31% of available shares are being sold short.
IonQ is set to report its third-quarter financial results after the market close on Nov. 8. According to estimates from Benzinga Pro, IonQ is expected to report a loss of 18 cents per share and quarterly revenue of $4.998 million.
Related News: What's Going On With SoFi Technologies Stock?
IONQ Price Action: According to Benzinga Pro, IonQ shares are up 3.63% at $9.99 at the time of publication.
Image: Gerd Altmann from Pixabay
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
